Literature DB >> 25019974

Sex-specific associations between Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cognitive domains in late-life depression.

P J W Naudé1, J A den Boer2, H C Comijs3, F J Bosker4, M Zuidersma4, N A Groenewold4, P P De Deyn5, P G M Luiten6, U L M Eisel6, R C Oude Voshaar4.   

Abstract

BACKGROUND: Although it is well established that late-life depression is associated with both systemic low-graded inflammation and cognitive impairment, the relation between inflammation and cognition in depressed older persons is still equivocal. The objective of this study is to examine the association between plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentrations and cognitive functioning in late-life depression, including the potentially moderating role of sex.
METHODS: A total of 369 depressed older persons (≥60 years) from The Netherlands study of Depression in Older persons (NESDO) were included. Four cognitive domains, i.e. verbal memory, processing speed, interference control and attention were assessed with three cognitive tests (Stroop test, Wais Digit span test, and Rey's verbal learning test). Multiple linear regression analyses were applied with the four cognitive domains as dependent variables adjusted for confounders.
RESULTS: The association between NGAL levels and specific cognitive domains were sex-specific. In women, higher NGAL levels were associated with impaired verbal memory and lower processing speed. In men, higher NGAL levels were associated with worse interference control. Higher NGAL levels were not associated with attention. No sex-specific associations of either high sensitivity C-reactive protein (hsCRP) or interleukin-6 (IL-6) with cognitive functioning were found.
CONCLUSION: This study shows sex-specific association of NGAL with cognitive functioning in late-life depression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Executive functioning; IL-6; Inflammation; Lipocalin 2; NESDO; Verbal memory; hsCRP

Mesh:

Substances:

Year:  2014        PMID: 25019974     DOI: 10.1016/j.psyneuen.2014.06.016

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  7 in total

Review 1.  A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression.

Authors:  Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

2.  Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.

Authors:  Elise V Mike; Hadijat M Makinde; Maria Gulinello; Kamala Vanarsa; Leal Herlitz; Gaurav Gadhvi; Deborah R Winter; Chandra Mohan; John G Hanly; C C Mok; Carla M Cuda; Chaim Putterman
Journal:  J Autoimmun       Date:  2018-08-30       Impact factor: 7.094

3.  Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.

Authors:  Lori N Eidson; George T Kannarkat; Christopher J Barnum; Jianjun Chang; Jaegwon Chung; Chelsea Caspell-Garcia; Peggy Taylor; Brit Mollenhauer; Michael G Schlossmacher; Larry Ereshefsky; Mark Yen; Catherine Kopil; Mark Frasier; Kenneth Marek; Vicki S Hertzberg; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2017-08-18       Impact factor: 8.322

4.  Electroacupuncture improves repeated social defeat stress-elicited social avoidance and anxiety-like behaviors by reducing Lipocalin-2 in the hippocampus.

Authors:  Yi-Hung Chen; Sheng-Yun Xie; Chao-Wei Chen; Dah-Yuu Lu
Journal:  Mol Brain       Date:  2021-09-26       Impact factor: 4.041

5.  Circulating Lipocalin-2 level is positively associated with cognitive impairment in patients with metabolic syndrome.

Authors:  Kanokporn Pinyopornpanish; Arintaya Phrommintikul; Chaisiri Angkurawaranon; Sirinart Kumfu; Salita Angkurawaranon; Uten Yarach; Nida Buawangpong; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

Review 6.  Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

Authors:  Debby Van Dam; Yannick Vermeiren; Alain D Dekker; Petrus J W Naudé; Peter P De Deyn
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.

Authors:  Doortje W Dekens; Petrus J W Naudé; Sebastiaan Engelborghs; Yannick Vermeiren; Debby Van Dam; Richard C Oude Voshaar; Ulrich L M Eisel; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.